Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Summary
This will be a prospective, double-blind randomized controlled clinical trial. There will be two arms of treatment: intervention and control group. Preoperatively patients will be allocated at random to receive ultrasound guided bilateral ESP block either with the local anesthetic (intervention group) normal saline (control group). The aim of this study is to examine the effect of ESP block to increase the Quality of Recovery (measured via QoR-15 total score) and decrease opioid consumption.
Official title: Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD) Undergoing Major Abdominal Surgery: A Double-Blind Randomized Control Trial
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
67
Start Date
2021-07-21
Completion Date
2025-03-01
Last Updated
2026-09-25
Healthy Volunteers
No
Conditions
Interventions
Ropivacaine
Ultrasound guided ESP block either with the local anesthetic of 0.5% of Ropivicane 20 mL bilaterally (intervention group) or normal saline (control group) before surgery which will take 5-10 minutes in a 1:1 ratio.
normal saline
Ultrasound guided bilateral ESP block either with normal saline
Locations (1)
Mount Sinai Hospital
Toronto, Ontario, Canada